Positions

Professor of Neurosurgery in the School of Medicine

2021 School of Medicine

Professor in Neurology in the School of Medicine

2021 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2003 School of Medicine

Education

M.D. 1998

1998 University of Sherbrooke (Canada)

Resident, Neurology

2003 University of Sherbrooke (Canada)

Fellow in Neuro-Oncology, Medicine

2005 Duke University

Clinical Trials

D2C7 + Anti-CD40 for Malignant Glioma

EAF223: Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)

Publications, Grants & Awards

• Grants (17)
• Academics Articles (143)
• Conference Pages (6)
• Book Sections (3)

Showing 1-5 of 17

An open-label, Phase 1b study to evaluate the safety and tolerability of eflornithine plus temozolomide in patients with newly diagnosed glioblastoma

2024-2028Orbus Therapeutics, Inc.

A Phase 1 Trial of D2C7-IT in Combination with an Fc-engineered Anti-CD40 Monoclonal Antibody (2141-V11) Administered Intratumorally via Convection-Enhanced Delivery Followed by Perilymphatic Injections of 2141-V11 and Assessment of the Tumor Monorai

2024-2027Exvade Bioscience Inc.

Randomized Phase 2 (Ph2) clinical trial of Lerapolturev (previously known as PVSRIPO) in recurrent glioblastoma (rGBM)

2024-2027Brain Tumor Research Charity

Phase I open label ascending dose study to assess the feasibility and safety of intermittent infusions of MTX110 administered by convection-enhanced delivery (CED) as a monotherapy or in combination with lomustine in patients with recurrent glioblast

2022-2026Midatech Pharma Plc

Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer

2014-2023National Institutes of Health

DCI Centers, Cancer Types & Labs

Preston Robert Tisch Brain Tumor Center

Offices & Contact

the Preston Robert Tisch Brain
Durham, NC
27710

Duke Box 3624
Durham, NC
27710